Regulation of gene expression by modulating microRNAs through Epigallocatechin-3-gallate in cancer.
Loganathan Chandramani Priya DharshiniAbul Kalam Azad MandalPublished in: Molecular biology reports (2024)
Cancer is an intricate ailment that has a higher death rate globally and is characterized by aberrant cell proliferation and metastasis in nature. Since the beginning of healthcare, natural products, especially those derived from plants, have been utilized to support human health. Green tea contains an essential catechin called epigallocatechin gallate, which has anti-proliferative, anti-mutagenic, anti-inflammatory, and antioxidative properties. The anticancer properties of EGCG have been extensively studied using pre-clinical cell culture and animal model systems. Dysregulated miRNA may be a biomarker since it influences the different characteristics of cancer like upholding proliferative signaling, cell death, invasiveness, metastasis, and angiogenesis. EGCG either elevates or lowers the expression of dysregulated miRNAs in cancer. Nonetheless, due to its anticancer properties, greater attention has been paid towards the development of efficient strategies for utilizing EGCG in cancer chemotherapy. This review summarizes the modifying effect of EGCG on miRNAs in cancer after briefly discussing the anticancer mechanisms of EGCG and the function of miRNAs in cancer.
Keyphrases
- papillary thyroid
- gene expression
- squamous cell
- healthcare
- cell proliferation
- lymph node metastasis
- anti inflammatory
- signaling pathway
- squamous cell carcinoma
- risk assessment
- human health
- childhood cancer
- poor prognosis
- dna methylation
- radiation therapy
- young adults
- cell cycle
- climate change
- working memory
- binding protein